Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Peptides Biosimilars market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Peptides Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Peptides Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Stada Arzneimittel AG
Amgen
Biocon
Mylan
Dr. Reddy's Laboratories
Celltrion
Pfizer
Teva Pahrmaceutical
Dr Reddy's Laboratories
Samsung Biologics
By Type:
Glucagon
Calcitonin
By End-User:
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptides Biosimilars Market
-
1.3 Market Segment by Type
1.3.1 Japan Peptides Biosimilars Market Size and Growth Rate of Glucagon from 2014 to 2026
1.3.2 Japan Peptides Biosimilars Market Size and Growth Rate of Calcitonin from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Peptides Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
1.4.2 Japan Peptides Biosimilars Market Size and Growth Rate of Chronic Diseases from 2014 to 2026
1.4.3 Japan Peptides Biosimilars Market Size and Growth Rate of Autoimmune Diseases from 2014 to 2026
1.4.4 Japan Peptides Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
1.4.5 Japan Peptides Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency from 2014 to 2026
1.4.6 Japan Peptides Biosimilars Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
1.4.7 Japan Peptides Biosimilars Market Size and Growth Rate of Other Diseases from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Peptides Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptides Biosimilars by Major Types
3.4.1 Market Size and Growth Rate of Glucagon
3.4.2 Market Size and Growth Rate of Calcitonin
4 Segmentation of Peptides Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptides Biosimilars by Major End-Users
4.4.1 Market Size and Growth Rate of Peptides Biosimilars in Oncology
4.4.2 Market Size and Growth Rate of Peptides Biosimilars in Chronic Diseases
4.4.3 Market Size and Growth Rate of Peptides Biosimilars in Autoimmune Diseases
4.4.4 Market Size and Growth Rate of Peptides Biosimilars in Blood Disorders
4.4.5 Market Size and Growth Rate of Peptides Biosimilars in Growth Hormone Deficiency
4.4.6 Market Size and Growth Rate of Peptides Biosimilars in Infectious Diseases
4.4.7 Market Size and Growth Rate of Peptides Biosimilars in Other Diseases
5 Market Analysis by Regions
-
5.1 Japan Peptides Biosimilars Production Analysis by Regions
-
5.2 Japan Peptides Biosimilars Consumption Analysis by Regions
6 Hokkaido Peptides Biosimilars Landscape Analysis
-
6.1 Hokkaido Peptides Biosimilars Landscape Analysis by Major Types
-
6.2 Hokkaido Peptides Biosimilars Landscape Analysis by Major End-Users
7 Tohoku Peptides Biosimilars Landscape Analysis
-
7.1 Tohoku Peptides Biosimilars Landscape Analysis by Major Types
-
7.2 Tohoku Peptides Biosimilars Landscape Analysis by Major End-Users
8 Kanto Peptides Biosimilars Landscape Analysis
-
8.1 Kanto Peptides Biosimilars Landscape Analysis by Major Types
-
8.2 Kanto Peptides Biosimilars Landscape Analysis by Major End-Users
9 Chubu Peptides Biosimilars Landscape Analysis
-
9.1 Chubu Peptides Biosimilars Landscape Analysis by Major Types
-
9.2 Chubu Peptides Biosimilars Landscape Analysis by Major End-Users
10 Kinki Peptides Biosimilars Landscape Analysis
-
10.1 Kinki Peptides Biosimilars Landscape Analysis by Major Types
-
10.2 Kinki Peptides Biosimilars Landscape Analysis by Major End-Users
11 Chugoku Peptides Biosimilars Landscape Analysis
-
11.1 Chugoku Peptides Biosimilars Landscape Analysis by Major Types
-
11.2 Chugoku Peptides Biosimilars Landscape Analysis by Major End-Users
12 Shikoku Peptides Biosimilars Landscape Analysis
-
12.1 Shikoku Peptides Biosimilars Landscape Analysis by Major Types
-
12.2 Shikoku Peptides Biosimilars Landscape Analysis by Major End-Users
13 Kyushu Peptides Biosimilars Landscape Analysis
-
13.1 Kyushu Peptides Biosimilars Landscape Analysis by Major Types
-
13.2 Kyushu Peptides Biosimilars Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Stada Arzneimittel AG
14.1.1 Stada Arzneimittel AG Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Amgen
14.2.1 Amgen Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Biocon
14.3.1 Biocon Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Mylan
14.4.1 Mylan Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Dr. Reddy's Laboratories
14.5.1 Dr. Reddy's Laboratories Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Celltrion
14.6.1 Celltrion Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Pfizer
14.7.1 Pfizer Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Teva Pahrmaceutical
14.8.1 Teva Pahrmaceutical Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Dr Reddy's Laboratories
14.9.1 Dr Reddy's Laboratories Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Samsung Biologics
14.10.1 Samsung Biologics Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 100 Figures and 154 Tables)
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Glucagon from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Calcitonin from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Chronic Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Autoimmune Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Other Diseases from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Peptides Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Peptides Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Peptides Biosimilars
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptides Biosimilars by Different Types from 2014 to 2026
-
Table Consumption Share of Peptides Biosimilars by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Glucagon
Figure Market Size and Growth Rate of Calcitonin
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Peptides Biosimilars by Different End-Users from 2014 to 2026
-
Table Consumption Share of Peptides Biosimilars by Different End-Users from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Chronic Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Autoimmune Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
Figure Japan Peptides Biosimilars Market Size and Growth Rate of Other Diseases from 2014 to 2026
-
Table Japan Peptides Biosimilars Production by Regions
-
Table Japan Peptides Biosimilars Production Share by Regions
-
Figure Japan Peptides Biosimilars Production Share by Regions in 2014
-
Figure Japan Peptides Biosimilars Production Share by Regions in 2018
-
Figure Japan Peptides Biosimilars Production Share by Regions in 2026
-
Table Japan Peptides Biosimilars Consumption by Regions
-
Table Japan Peptides Biosimilars Consumption Share by Regions
-
Figure Japan Peptides Biosimilars Consumption Share by Regions in 2014
-
Figure Japan Peptides Biosimilars Consumption Share by Regions in 2018
-
Figure Japan Peptides Biosimilars Consumption Share by Regions in 2026
-
Table Hokkaido Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Hokkaido Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Hokkaido Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Hokkaido Peptides Biosimilars Consumption Share by Types in 2026
-
Table Hokkaido Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Hokkaido Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Hokkaido Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Tohoku Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Tohoku Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Tohoku Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Tohoku Peptides Biosimilars Consumption Share by Types in 2026
-
Table Tohoku Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Tohoku Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Tohoku Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Tohoku Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Kanto Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Kanto Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kanto Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Kanto Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Kanto Peptides Biosimilars Consumption Share by Types in 2026
-
Table Kanto Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kanto Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Kanto Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Kanto Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Chubu Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Chubu Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chubu Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Chubu Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Chubu Peptides Biosimilars Consumption Share by Types in 2026
-
Table Chubu Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chubu Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Chubu Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Chubu Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Kinki Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Kinki Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kinki Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Kinki Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Kinki Peptides Biosimilars Consumption Share by Types in 2026
-
Table Kinki Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kinki Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Kinki Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Kinki Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Chugoku Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Chugoku Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Chugoku Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Chugoku Peptides Biosimilars Consumption Share by Types in 2026
-
Table Chugoku Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chugoku Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Chugoku Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Chugoku Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Shikoku Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Shikoku Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Shikoku Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Shikoku Peptides Biosimilars Consumption Share by Types in 2026
-
Table Shikoku Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Shikoku Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Shikoku Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Shikoku Peptides Biosimilars Consumption Share by End-Users in 2026
-
Table Kyushu Peptides Biosimilars Consumption by Types from 2014 to 2026
-
Table Kyushu Peptides Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Peptides Biosimilars Consumption Share by Types in 2014
-
Figure Kyushu Peptides Biosimilars Consumption Share by Types in 2018
-
Figure Kyushu Peptides Biosimilars Consumption Share by Types in 2026
-
Table Kyushu Peptides Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kyushu Peptides Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Peptides Biosimilars Consumption Share by End-Users in 2014
-
Figure Kyushu Peptides Biosimilars Consumption Share by End-Users in 2018
-
Figure Kyushu Peptides Biosimilars Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Stada Arzneimittel AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stada Arzneimittel AG
Figure Sales and Growth Rate Analysis of Stada Arzneimittel AG
Figure Revenue and Market Share Analysis of Stada Arzneimittel AG
Table Product and Service Introduction of Stada Arzneimittel AG
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of Biocon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
Figure Sales and Growth Rate Analysis of Biocon
Figure Revenue and Market Share Analysis of Biocon
Table Product and Service Introduction of Biocon
Table Company Profile and Development Status of Mylan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
Figure Sales and Growth Rate Analysis of Mylan
Figure Revenue and Market Share Analysis of Mylan
Table Product and Service Introduction of Mylan
Table Company Profile and Development Status of Dr. Reddy's Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories
Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories
Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories
Table Product and Service Introduction of Dr. Reddy's Laboratories
Table Company Profile and Development Status of Celltrion
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
Figure Sales and Growth Rate Analysis of Celltrion
Figure Revenue and Market Share Analysis of Celltrion
Table Product and Service Introduction of Celltrion
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Teva Pahrmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pahrmaceutical
Figure Sales and Growth Rate Analysis of Teva Pahrmaceutical
Figure Revenue and Market Share Analysis of Teva Pahrmaceutical
Table Product and Service Introduction of Teva Pahrmaceutical
Table Company Profile and Development Status of Dr Reddy's Laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
Table Product and Service Introduction of Dr Reddy's Laboratories
Table Company Profile and Development Status of Samsung Biologics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Biologics
Figure Sales and Growth Rate Analysis of Samsung Biologics
Figure Revenue and Market Share Analysis of Samsung Biologics
Table Product and Service Introduction of Samsung Biologics
-
